![Hugh MacNaught](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 29 299 $ as of 30/06/2026
Mr. Hugh MacNaught is a President, Chief Executive Officer & Director at VentriPoint Diagnostics Ltd. and a Chief Executive Officer at Nanologix Research, Inc. He is on the Board of Directors at VentriPoint Diagnostics Ltd. Mr. MacNaught was previously employed as an Executive Vice President by biOasis Technologies, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/07/2026 | 375,634 ( 0.2% ) | 29 299 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Chief Executive Officer | 05/02/2024 |
Nanologix Research, Inc. | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Director/Board Member | 01/10/2020 |
| BIOASIS TECHNOLOGIES INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
VentriPoint Diagnostics Ltd.
 VentriPoint Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures cardiac imaging systems | Health Technology |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Nanologix Research, Inc. |
Select your edition
All financial news and data tailored to specific country editions
